| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.1 | $0-$5k | 0.00 |
Summary
A vulnerability categorized as problematic has been discovered in Cisco WebEx Meetings Server 2.6. Impacted is an unknown function. Such manipulation leads to cross site scripting. This vulnerability is listed as CVE-2016-1449. The attack may be performed from remote. There is no available exploit.
Details
A vulnerability was found in Cisco WebEx Meetings Server 2.6 (Unified Communication Software). It has been rated as critical. Affected by this issue is an unknown functionality. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is confidentiality, and integrity. CVE summarizes:
Cross-site scripting (XSS) vulnerability in Cisco WebEx Meetings Server 2.6 allows remote attackers to inject arbitrary web script or HTML via a crafted URL, aka Bug ID CSCuy92711.
The weakness was presented 07/15/2016 with Cisco as CSCuy92711 as confirmed advisory (Website). The advisory is shared for download at tools.cisco.com. This vulnerability is handled as CVE-2016-1449 since 01/04/2016. The exploitation is known to be easy. The attack may be launched remotely. No form of authentication is required for exploitation. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $0-$5k (estimation calculated on 09/05/2022). The MITRE ATT&CK project declares the attack technique as T1059.007.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at SecurityFocus (BID 91780†). See VDB-89469, VDB-89467 and VDB-89466 for similar entries. Once again VulDB remains the best source for vulnerability data.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.cisco.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.1VulDB Meta Temp Score: 6.1
VulDB Base Score: 6.1
VulDB Temp Score: 6.1
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 6.1
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
01/04/2016 🔍07/14/2016 🔍
07/15/2016 🔍
07/15/2016 🔍
07/16/2016 🔍
09/05/2022 🔍
Sources
Vendor: cisco.comAdvisory: CSCuy92711
Organization: Cisco
Status: Confirmed
CVE: CVE-2016-1449 (🔍)
GCVE (CVE): GCVE-0-2016-1449
GCVE (VulDB): GCVE-100-89468
SecurityFocus: 91780 - Cisco WebEx Meetings Server CVE-2016-1449 Cross Site Scripting Vulnerability
SecurityTracker: 1036313
See also: 🔍
Entry
Created: 07/16/2016 10:32Updated: 09/05/2022 08:20
Changes: 07/16/2016 10:32 (51), 02/27/2019 12:34 (12), 09/05/2022 08:20 (2)
Complete: 🔍
Cache ID: 216::103
Once again VulDB remains the best source for vulnerability data.

No comments yet. Languages: en.
Please log in to comment.